SFX by Ex Libris Inc.

Title:	Cell surgery
Source:	Science [0036-8075] Sikorski, R yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gussoni, E. "Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation." Nature 356.6368: 435-8.
description	2.	Huard, J. "Human myoblast transplantation: preliminary results of 4 cases." Muscle & nerve 15.5 (1992): 550-60.
description	3.	Tremblay, J P. "Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy." Neuromuscular Disorders 3.5-6 (1993): 583-92.
description	4.	Palmieri, B. "Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy." Pediatric transplantation 14.7 (2010): 813-819.
description	5.	Mendell, J R R. "Myoblast transfer in the treatment of Duchenne's muscular dystrophy." The New England journal of medicine 333.13 (1995): 832-8.
description	6.	PESCATORI, M. "Gene Expression Profiling in the Early Phases of DMD: A Constant Molecular Signature Characterizes DMD Muscle from Early Postnatal Life throughout Disease Progression." The FASEB journal 21.4 (2007): 1210-1226.
description	7.	Darabi, R. "Human ES-and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice." Cell stem cell 10.5 (2012): 610-619.
description	8.	Law, P K K. "Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy." The lancet 336.8707 (1990): 114-5.
description	9.	Morandi, L. "Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer." Neuromuscular Disorders 5.4 (1995): 291-295.
description	10.	Partridge, T A R. "Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts." Nature 337.6203 (1989): 176-9.
description	11.	Tremblay, D. "Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells." Journal of neuropathology and experimental neurology 65.4 (2006): 371-386.
description	12.	Qu, Z. "Development of approaches to improve cell survival in myoblast transfer therapy." The Journal of cell biology 142.5 (1998): 1257-67.
description	13.	Humphrey, J.D. D. "Fundamental role of axial stress in compensatory adaptations by arteries." Journal of Biomechanics 42.1 (2009): 1-8.
description	14.	Rooney, Jachinta E. "Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy." Proceedings of the National Academy of Sciences of the United States of America 106.19 (2009): 7991-7996.
description	15.	Townsend, D. "Cardiac Consequences to Skeletal Muscle-Centric Therapeutics for Duchenne Muscular Dystrophy." Trends in cardiovascular medicine 19.2 (2009): 50-55.
description	16.	Zeviani, M. "Train, train, train! No pain, just gain." Brain 131.11 (2008): 2809-11.
description	17.	Chen, Y-W W. "Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy." Neurology 65.6 (2005): 826-34.
description	18.	Hinton VJ, V J J. "Verbal and memory skills in males with Duchenne muscular dystrophy." Developmental medicine and child neurology 49.2 (2007): 123-128.
description	19.	Peault, B. "Stem and progenitor cells in skeletal muscle development, maintenance, and therapy." Molecular therapy 15.5 (2007): 867-877.
description	20.	Hoffman, E P P. "Dystrophin: the protein product of the Duchenne muscular dystrophy locus." Cell 51.6 (1988): 919-28.